Approximately 15% of TNBC harbor a germline mutation in BRCA1 or BRCA2; up to 80% of BRCA1 mutation-associated and 35% of BRCA2 mutation-associated breast cancer has the TNBC phenotype [6, 7]. Here, BRCA2 is linked to breast carcinoma.